المؤلفون: Fuchs, M., Jacob, A.S., Kaul, H., Kobe, C., Kuhnert, G., Pabst, T., Greil, R., Bröckelmann, P.J., Topp, M.S., Just, M., Hertenstein, B., Soekler, M., Vogelhuber, M., Zijlstra, J.M., Keller, U.B., Krause, S.W., Dührsen, U., Meissner, J., Viardot, A., Eich, H.T., Baues, C., Diehl, V., Rosenwald, A., Buehnen, I., von Tresckow, B., Dietlein, M., Borchmann, P., Engert, A., Eichenauer, D.A.

مصطلحات موضوعية: Cancer Research

وصف الملف: application/pdf; other

العلاقة: http://edoc.mdc-berlin.de/23852/1/23852oa.pdfTest; http://edoc.mdc-berlin.de/23852/2/23852suppl.docxTest; Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Fuchs, M. and Jacob, A.S. and Kaul, H. and Kobe, C. and Kuhnert, G. and Pabst, T. and Greil, R. and Bröckelmann, P.J. and Topp, M.S. and Just, M. and Hertenstein, B. and Soekler, M. and Vogelhuber, M. and Zijlstra, J.M. and Keller, U.B. and Krause, S.W. and Dührsen, U. and Meissner, J. and Viardot, A. and Eich, H.T. and Baues, C. and Diehl, V. and Rosenwald, A. and Buehnen, I. and von Tresckow, B. and Dietlein, M. and Borchmann, P. and Engert, A. and Eichenauer, D.A. Leukemia 38 (1): 160-167. January 2024

الإتاحة: https://doi.org/10.1038/s41375-023-02064-yTest
http://edoc.mdc-berlin.de/23852Test/
https://edoc.mdc-berlin.de/23852Test/
http://edoc.mdc-berlin.de/23852/1/23852oa.pdfTest
http://edoc.mdc-berlin.de/23852/2/23852suppl.docxTest

المؤلفون: Damaschin, C., Goergen, H., Kreissl, S., Plütschow, A., Breywisch, F., Mathas, S., Meissner, J., Sökler, M., Topp, M.S., Vucinic, V., Zimmermann, A., von Tresckow, B., Fuchs, M., Engert, A., Borchmann, P., Eichenauer, D.A.

مصطلحات موضوعية: Cancer Research, Topic 3: Integrative Biomedicine

وصف الملف: application/pdf

العلاقة: http://edoc.mdc-berlin.de/20855/1/20855oa.pdfTest; Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Damaschin, C. and Goergen, H. and Kreissl, S. and Plütschow, A. and Breywisch, F. and Mathas, S. and Meissner, J. and Sökler, M. and Topp, M.S. and Vucinic, V. and Zimmermann, A. and von Tresckow, B. and Fuchs, M. and Engert, A. and Borchmann, P. and Eichenauer, D.A. Leukemia 36 (2): 580-582. February 2022

الإتاحة: https://doi.org/10.1038/s41375-021-01386-zTest
http://edoc.mdc-berlin.de/20855Test/
https://edoc.mdc-berlin.de/20855Test/
http://edoc.mdc-berlin.de/20855/1/20855oa.pdfTest

المؤلفون: Thuss-Patience, P.C., Al-Batran, S-E., Pauligk, C., Goekkurt, E., Ettrich, T.J., Lordick, F., Stahl, M., Reichardt, P., Soekler, M., Pink, D., Probst, S., Hinke, A., Götze, T.O., Lorenzen, S.

المصدر: Annals of Oncology ; volume 31, page S928 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.2001Test
https://api.elsevier.com/content/article/PII:S0923753420419970?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420419970?httpAccept=text/plainTest

المؤلفون: Seymour, JF, Marcus, R, Davies, A, Gallop-Evans, E, Grigg, A, Haynes, A, Herold, M, Illmer, T, Nilsson-Ehle, H, Soekler, M, Duenzinger, U, Nielsen, T, Launonen, A, Hiddemann, W

العلاقة: pii: haematol.2018.209015; Seymour, J. F., Marcus, R., Davies, A., Gallop-Evans, E., Grigg, A., Haynes, A., Herold, M., Illmer, T., Nilsson-Ehle, H., Soekler, M., Duenzinger, U., Nielsen, T., Launonen, A. & Hiddemann, W. (2019). Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression. HAEMATOLOGICA, 104 (6), pp.1202-1208. https://doi.org/10.3324/haematol.2018.209015Test.; http://hdl.handle.net/11343/251218Test

الإتاحة: https://doi.org/10.3324/haematol.2018.209015Test
http://hdl.handle.net/11343/251218Test

المؤلفون: Kaddu-Mulindwa, D., Lesan, V., Berdel, C., Stilgenbauer, S., Bewarder, M., Thurner, L., Witzens-Harig, M., Viardot, A., Soekler, M., Keller, U., Truemper, L., Christofyllakis, K., Fleser, O., Bittenbring, J.T., Poeschel, V., Held, G., Jagoda, P.

مصطلحات موضوعية: Cancer Research

العلاقة: Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Kaddu-Mulindwa, D. and Lesan, V. and Berdel, C. and Stilgenbauer, S. and Bewarder, M. and Thurner, L. and Witzens-Harig, M. and Viardot, A. and Soekler, M. and Keller, U. and Truemper, L. and Christofyllakis, K. and Fleser, O. and Bittenbring, J.T. and Poeschel, V. and Held, G. and Jagoda, P. Leukemia & Lymphoma 63 (2): 326-334. February 2022

الإتاحة: https://doi.org/10.1080/10428194.2021.1975193Test
http://edoc.mdc-berlin.de/21011Test/
https://edoc.mdc-berlin.de/21011Test/

المؤلفون: Kreissl, S., Goergen, H., Buehnen, I., Kobe, C., Moccia, A., Greil, R., Eichenauer, D.A., Zijlstra, J.M., Markova, J., Meissner, J., Feuring-Buske, M., Soekler, M., Beck, H.J., Willenbacher, W., Ludwig, W.D., Pabst, T., Topp, M.S., Hitz, F., Bentz, M., Keller, U.B., Kühnhardt, D., Ostermann, H., Hertenstein, B., Aulitzky, W., Maschmeyer, G., Vieler, T., Eich, H., Baues, C., Stein, H., Fuchs, M., Diehl, V., Dietlein, M., Engert, A., Borchmann, P.

مصطلحات موضوعية: Cancer Research

العلاقة: PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. Kreissl, S. and Goergen, H. and Buehnen, I. and Kobe, C. and Moccia, A. and Greil, R. and Eichenauer, D.A. and Zijlstra, J.M. and Markova, J. and Meissner, J. and Feuring-Buske, M. and Soekler, M. and Beck, H.J. and Willenbacher, W. and Ludwig, W.D. and Pabst, T. and Topp, M.S. and Hitz, F. and Bentz, M. and Keller, U.B. and Kühnhardt, D. and Ostermann, H. and Hertenstein, B. and Aulitzky, W. and Maschmeyer, G. and Vieler, T. and Eich, H. and Baues, C. and Stein, H. and Fuchs, M. and Diehl, V. and Dietlein, M. and Engert, A. and Borchmann, P. Lancet Haematology 8 (6): e398-e409. June 2021

الإتاحة: https://doi.org/10.1016/S2352-3026Test(21)00101-0
http://edoc.mdc-berlin.de/20368Test/
https://edoc.mdc-berlin.de/20368Test/

المؤلفون: Borchmann, P., Plütschow, A., Kobe, C., Greil, R., Meissner, J., Topp, M.S., Ostermann, H., Dierlamm, J., Mohm, J., Thiemer, J., Sökler, M., Kerkhoff, A., Ahlborn, M., Halbsguth, T.V., Martin, S., Keller, U., Balabanov, S., Pabst, T., Vogelhuber, M., Hüttmann, A., Wilhelm, M., Zijlstra, J.M., Moccia, A., Kuhnert, G., Bröckelmann, P.J., von Tresckow, B., Fuchs, M., Klimm, B., Rosenwald, A., Eich, H., Baues, C., Marnitz, S., Hallek, M., Diehl, V., Dietlein, M., Engert, A.

مصطلحات موضوعية: Cancer Research

العلاقة: PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. Borchmann, P. and Plütschow, A. and Kobe, C. and Greil, R. and Meissner, J. and Topp, M.S. and Ostermann, H. and Dierlamm, J. and Mohm, J. and Thiemer, J. and Sökler, M. and Kerkhoff, A. and Ahlborn, M. and Halbsguth, T.V. and Martin, S. and Keller, U. and Balabanov, S. and Pabst, T. and Vogelhuber, M. and Hüttmann, A. and Wilhelm, M. and Zijlstra, J.M. and Moccia, A. and Kuhnert, G. and Bröckelmann, P.J. and von Tresckow, B. and Fuchs, M. and Klimm, B. and Rosenwald, A. and Eich, H. and Baues, C. and Marnitz, S. and Hallek, M. and Diehl, V. and Dietlein, M. and Engert, A. Lancet Oncology 22 (2): 223-234. February 2021

الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30601-X
http://edoc.mdc-berlin.de/19978Test/
https://edoc.mdc-berlin.de/19978Test/

المؤلفون: Poeschel V., Held G., Ziepert M., Witzens-Harig M., Holte H., Thurner L., Borchmann P., Viardot A., Soekler M., Keller U., Schmidt C., Truemper L., Mahlberg R., Marks R., Hoeffkes H. -G., Metzner B., Dierlamm J., Frickhofen N., Haenel M., Neubauer A., Kneba M., Merli F., Tucci A., de Nully Brown P., Federico M., Lengfelder E., di Rocco A., Trappe R., Rosenwald A., Berdel C., Maisenhoelder M., Shpilberg O., Amam J., Christofyllakis K., Hartmann F., Murawski N., Stilgenbauer S., Nickelsen M., Wulf G., Glass B., Schmitz N., Altmann B., Loeffler M., Pfreundschuh M.

المساهمون: Poeschel, V., Held, G., Ziepert, M., Witzens-Harig, M., Holte, H., Thurner, L., Borchmann, P., Viardot, A., Soekler, M., Keller, U., Schmidt, C., Truemper, L., Mahlberg, R., Marks, R., Hoeffkes, H. -G., Metzner, B., Dierlamm, J., Frickhofen, N., Haenel, M., Neubauer, A., Kneba, M., Merli, F., Tucci, A., de Nully Brown, P., Federico, M., Lengfelder, E., di Rocco, A., Trappe, R., Rosenwald, A., Berdel, C., Maisenhoelder, M., Shpilberg, O., Amam, J., Christofyllakis, K., Hartmann, F., Murawski, N., Stilgenbauer, S., Nickelsen, M., Wulf, G., Glass, B., Schmitz, N., Altmann, B., Loeffler, M., Pfreundschuh, M.

مصطلحات موضوعية: Administration, Intravenou, Oral, Adult, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Cyclophosphamide, Denmark, Doxorubicin, Drug Administration Schedule, Female, Germany, Human, International Cooperation, Israel, Italy, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Neoplasm Staging, Norway, Prednisone, Prospective Studie, Rituximab, Survival Analysi, Treatment Outcome, Vincristine

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31868632; info:eu-repo/semantics/altIdentifier/wos/WOS:000503788300030; volume:394; issue:10216; firstpage:2271; lastpage:2281; journal:THE LANCET; http://hdl.handle.net/11380/1201648Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85076743072

الإتاحة: https://doi.org/10.1016/S0140-6736Test(19)33008-9
http://hdl.handle.net/11380/1201648Test

المؤلفون: Reinke, S., Bröckelmann, P.J., Iaccarino, I., Garcia-Marquez, M., Borchmann, S., Jochims, F., Kotrova, M., Pal, K., Brüggemann, M., Hartmann, E., Sasse, S., Kobe, C., Mathas, S., Soekler, M., Keller, U., Bormann, M., Zimmermann, A., Richter, J., Fuchs, M., von Tresckow, B., Borchmann, P., Schlößer, H., von Bergwelt-Baildon, M., Rosenwald, A., Engert, A., Klapper, W.

مصطلحات موضوعية: Cancer Research

العلاقة: Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Reinke, S. and Bröckelmann, P.J. and Iaccarino, I. and Garcia-Marquez, M. and Borchmann, S. and Jochims, F. and Kotrova, M. and Pal, K. and Brüggemann, M. and Hartmann, E. and Sasse, S. and Kobe, C. and Mathas, S. and Soekler, M. and Keller, U. and Bormann, M. and Zimmermann, A. and Richter, J. and Fuchs, M. and von Tresckow, B. and Borchmann, P. and Schlößer, H. and von Bergwelt-Baildon, M. and Rosenwald, A. and Engert, A. and Klapper, W. Blood 136 (25): 2851-2863. 17 December 2020

الإتاحة: https://doi.org/10.1182/blood.2020008553Test
http://edoc.mdc-berlin.de/19524Test/
https://edoc.mdc-berlin.de/19524Test/

المؤلفون: Seymour, JF, Marcus, R, Davies, A, Gallop-Evans, E, Grigg, A, Haynes, A, Herold, M, Illmer, T, Nilsson-Ehle, H, Soekler, M, Duenzinger, U, Nielsen, T, Launonen, A, Hiddemann, W

العلاقة: pii: haematol.2020.246991; Seymour, J. F., Marcus, R., Davies, A., Gallop-Evans, E., Grigg, A., Haynes, A., Herold, M., Illmer, T., Nilsson-Ehle, H., Soekler, M., Duenzinger, U., Nielsen, T., Launonen, A. & Hiddemann, W. (2020). Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression (vol 104, pg 1202, 2019). HAEMATOLOGICA, 105 (5), pp.1465-1465. https://doi.org/10.3324/haematol.2020.246991Test.; http://hdl.handle.net/11343/254194Test

الإتاحة: https://doi.org/10.3324/haematol.2020.246991Test
http://hdl.handle.net/11343/254194Test